Fairmount Funds Management LLC Diversified Active

CIK: 0001802528 · Show all filings

Period: Q2 2021 (← Previous) (Next →)

Filing Date: Aug 13, 2021

Total Value ($000): $243,235 (100.0% shares, 0.0% debt)

Holdings (19)

INSM INSMED INC 15.0%
Value ($000) $36,539 Shares 1,283,887 Est. Cost $23.03 Unrealized +28.9%
ZOGENIX INC 14.0%
Value ($000) $34,046 Shares 1,970,259 Est. Cost $27.22 Unrealized
AXSM AXSOME THERAPEUTICS INC 8.7%
Value ($000) $21,088 Shares 312,598 Est. Cost $75.74 Unrealized -20.8%
ARGX ARGENX SE 8.6%
Value ($000) $20,817 Shares 69,144 Est. Cost $198.98 Unrealized
IOVA IOVANCE BIOTHERAPEUTICS INC 5.4%
Value ($000) $13,163 Shares 505,890 Est. Cost $24.87 Unrealized +4.5%
INSTIL BIO INC 5.4%
Value ($000) $13,020 Shares 673,905 Est. Cost $24.02 Unrealized
ALLAKOS INC 5.3%
Value ($000) $12,990 Shares 152,162 Est. Cost $81.25 Unrealized
COGT COGENT BIOSCIENCES INC 5.2%
Value ($000) $12,643 Shares 1,558,975 Est. Cost $10.99 Unrealized -23.1%
AMARIN CORP PLC 4.6%
Value ($000) $11,096 Shares 2,533,237 Est. Cost $10.64 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 4.2%
Value ($000) $10,337 Shares 423,817 Est. Cost $43.17 Unrealized -47.7%
THERAPEUTICS ACQUISITION COR 3.6%
Value ($000) $8,875 Shares 864,214 Est. Cost $10.28 Unrealized
TRILLIUM THERAPEUTICS INC 3.6%
Value ($000) $8,694 Shares 896,281 Est. Cost $4.53 Unrealized
CATABASIS PHARMACEUTICALS IN 3.5%
Value ($000) $8,634 Shares 4,092,166 Est. Cost $2.12 Unrealized
FOLD AMICUS THERAPEUTICS INC 3.5%
Value ($000) $8,570 Shares 888,980 Est. Cost $9.80 Unrealized -0.3%
ENTA ENANTA PHARMACEUTICALS INC 3.2%
Value ($000) $7,836 Shares 178,058 Est. Cost $59.73 Unrealized -18.0%
GLOBAL BLOOD THERAPEUTICS IN 3.0%
Value ($000) $7,354 Shares 210,000 Est. Cost $41.93 Unrealized
KROS KEROS THERAPEUTICS INC 2.6%
Value ($000) $6,342 Shares 149,333 Est. Cost $60.90 Unrealized -11.0%
VRDN VIRIDIAN THERAPEUTICS INC 0.3%
Value ($000) $642 Shares 35,092 Est. Cost $18.72 Unrealized -8.6%
VERONA PHARMA PLC 0.2%
Value ($000) $549 Shares 83,944 Est. Cost $6.24 Unrealized